Clinical Trial Update: A Study of ABT-652 in Combination With a Nonsteroidal Anti-Inflammatory Drug (NSAID) in Adults With Osteoarthritis Pain of the Knee [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating ABT-652 in combination with a nonsteroidal anti-inflammatory drug for knee osteoarthritis pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• ABT-652

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Osteoarthritis of the Knee | Phase 2 | Status: COMPLETED